AD04 Advancing to Phase III Amid Promising Results in Alcohol Use Disorder

admin January 22, 2025 No Comments

Cary Claiborne, CEO, Adial Pharmaceuticals, discusses AD04’s development timeline and next steps towards approval for alcohol use disorder.

Medicine